Welcome to the
Target Communities: ME/CFS and FM
To Get Started
Join one of our Communities (to get your ID)
Read and complete the FORMS below
Order yourself some Whey Protein
Make you baseline measurements
If you were planning on trying Whey Protein as a treatment feel free to use the information and services here to help you make a more thorough evaluation. Note that Mendus does not run traditional scientific studies. Rather, we provide information that allows people to test things for themselves. It is then up to you whether to share your results with the community. The information here does not constitute medical advice. We strongly advise consulting a physician before following guidelines.
Order Your Whey Protein
You are not obliged to purchase your D-Ribose from these sources but doing so will: a) get you a good product at a decent price, b) make sure we all use the same/similar product and c) you'll support Mendus by doing so
Complete once for each type of whey
Complete at each measurement timepoint
Enter Your Data
How to Download Your Data
Type your ID in the small box (e.g. FM123456 or CFS000001)
Click "Create Download URL"
Copy the text in the long box
Paste that into the address bar of your internet browser
It may take a few minutes but a text file will automatically download.
The downloaded file can be opened in many programs including Microsoft Excel, Google Sheets, SPSS and any text editor. All of your data from THIS study will in the file. To get your data from other studies you will need to follow the same procedure on that study homepage. If you download your data again in the future any new entries will be added to the older ones. That is, you'll always be downloading your entire dataset.
To view all of the data you have entered (for this study) choose the appropriate group and enter your ID on the following page. If enough people have completed the study there will be group results displayed by default.
A double-blind, randomized, placebo-controlled ME/CFS cohort
A double-blind, randomized, placebo-controlled fibromyalgia cohort